Health Care Knowledge

If we talk about cancer, then in cancer certain cells in the body grow and multiply in an out of control way. Anti-cancer medicines, which can be also addressed as chemotherapy, work by inhibiting the way cells grow and increase in number. Gefitinib mainly belongs to a group of anti-cancer (chemotherapy) medicines known as tyrosine kinase inhibitors. These anti-cancer medications effectfully work by blocking chemical messengers, called tyrosine kinases, which is effective as well as helpful in sending signals to cells to grow. This helps in order to stop cancerous cells from growing and spreading. Gefitinib is the first-line metastatic non-small cell lung cancer medication (NSCLC) whose tumors have epidermal growth factor receptor (EGFR) exon 19 deletions or exon 21 (L858R) substitution mutations as detected by an FDA-approved test. Side effects of Gefitinib: Sometimes Gefitinib 250 mg tablets may leave some adverse effects on patients who are taking this medication. Some

NSCLC, the most common form of lung cancer. It occurs when the healthy cells in the lung change and start growing in an abnormal way, forming a specific mass addressed as tumor, lesion, or nodule. A tumor may develop anywhere in the lung and could be cancerous or benign. A cancerous tumor mainly is malignant, means, it has potential in order to spread to the rest part of the body. A benign tumor is the tumor that can grow but can not spread.  Non-Small Cell Lung Cancer (NSCLC) occurs in the epithelial cells. Doctors can also describe this form of Cancer (NSCLC) based on the type of the epithelial cell where the cancer usually starts.  Adenocarcinoma starts in cells that produce mucus.  Squamous carcinoma basically developed in the cells that line the airways.  Large cell carcinoma usually begins in the cells other than the two types which are described above.  It’s necessary for healthcare providers to distinguish between lung cancer that begins in the squamous cells from lung cancer

Lopinavir & Ritonavir is a fixed-dose combination drug in order to treat as well as prevent HIV/AIDS. It combines lopinavir with a small dose of ritonavir.  Also, it is recommended for use with the other antiretrovirals. Lopinavir and Ritonavir are the class of medications commonly known as protease inhibitors. These medications work by resisting and decreasing the amount of HIV in the blood. Taking both these medications along with practicing safer sex may prevent the transmitting HIV virus to other people. Apart from this Ritonavir-Lopinavir may be used for the prevention after the needlestick injury as well as other potential exposure. In the year 2000, Lopinavir-Ritonavir was approved in the form of a single medication. It is the most effective and safest medication on the World Health Organization's list of essential medications. Side effects of Lopinavir-Ritonavir: People with this medication may experience a few most common side effects include feelin